Home › Industries › Research and Development in Biotechnology (except Nanobiotechnology)
Recompete pipeline in Research and Development in Biotechnology (except Nanobiotechnology)
NAICS 541714
$498.9MCeiling value on the cliff
4Contracts expiring ≤ 18 mo
Federal contracts classified under NAICS 541714 (Research and Development in Biotechnology (except Nanobiotechnology)) that reach the end of their current period of performance within 18 months, sorted soonest first.
| Incumbent | Agency | Ceiling value | Ends | Expiry |
|---|---|---|---|---|
| SEATTLE CHILDREN'S HOSPITAL
75N93019C00070 |
Department of Health and Human Services National Institutes of Health | $86,597,961 | 2027-03-31 | in 7 months |
| CROSSJECT SA
75A50122C00031 |
Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | $104,152,986 | 2027-06-21 | in 10 months |
| ALBERT B. SABIN VACCINE INSTITUTE, INC. (THE)
75A50119C00055 |
Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | $147,062,009 | 2027-09-30 | in 13 months |
| ADVANCED TECHNOLOGY INTERNATIONAL
75A50123F61005 |
Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | $161,082,263 | 2027-12-31 | in 16 months |
"Expiring" is the current period-of-performance end date recorded on USAspending.gov (U.S. Treasury); it signals a
likely recompete but does not guarantee one. See the method.